‘Concierge Service’ for FDA’s Experimental Drug Program Coming

May 22, 2019

The Food and Drug Administration’s (FDA) oncology chief wants to create a one-stop shop so cancer patients and their doctors do not have to wade through bureaucracy that could curtail access to potentially life-saving experimental medicines.